{"url_path":"/sec/coch/8-k/2026-06-30/item-1-02","section_key":"item-1-02","section_title":"Item 1.02 ** **Termination of a Material Definitive Agreement**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-073659-index.html","accession_number":"0001213900-26-073659","cik":"0001840877","ticker":"COCH","issuer_name":"Envoy Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-073659-index.html","primary_entity_key":"0001840877","primary_entity_name":"Envoy Medical, Inc."},"word_count":159,"has_tables":true,"body_markdown":"**Item 1.02** **Termination of a Material Definitive Agreement**\n\n \n\nOn June 24, 2026, Envoy Medical, Inc. (the “Company”) terminated\nits At The Market Offering Agreement, dated January 17, 2025 (the “ATM Agreement”).\n\n \n\nThe ATM Agreement was filed as Exhibit 10.1 to the Company’s\nCurrent Report on Form 8-K dated January 17, 2025.\n\n \n\nA copy of a press release issued by the Company on June 24, 2026 regarding\ntermination of the ATM Agreement is attached hereto as Exhibit 99.1. The information set forth Exhibit 99.1 is being furnished and shall\nnot be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),\nor otherwise subject to the liabilities of that Section. The information in Exhibit 99.1 shall not be deemed incorporated by reference\ninto any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific\nreference in such a filing."}